atempo logo-1
0
 Free Shipping on Orders over $50 SHOP NOW   

Berberine with Ceylon Cinnamon: A Powerful Duo for Blood Sugar Balance

Table of Contents

In today’s fast-paced world, managing blood sugar levels is crucial for maintaining optimal health and preventing chronic conditions. At Atempo Naturals, we understand the importance of natural, effective solutions. That’s why we offer a premium Berberine with Ceylon Cinnamon supplement, combining two scientifically backed herbs to support metabolic health without any fillers.

The Role of Carbohydrates in Energy and Health

Carbohydrates are a primary energy source, fueling the brain and body. On average, carbohydrates account for about half of our daily energy intake. However, the human body can store only around 1 kg of glucose in the liver and muscles—barely enough for two days. Beyond this, glucose levels must be carefully managed to avoid adverse health effects.

Excess glucose in the blood is linked to:

  • Metabolic disorders like obesity and type 2 diabetes [1], [2].
  • Chronic inflammation and pain [4], [5].
  • Accelerated ageing and cardiovascular risks [3].
  • Even an increased risk of cancer [6].

While medications such as sulfonylureas and glinides stimulate insulin production, they may cause dangerous hypoglycemia. This is where natural solutions like berberine and Ceylon cinnamon excel, offering blood sugar regulation without such risks.

The Science Behind Berberine

Berberine, a plant-derived compound, has gained recognition for its ability to lower blood sugar without inducing hypoglycemia. Its benefits include:

  • Blood sugar regulation: Berberine improves insulin sensitivity and reduces markers of insulin resistance [7].
  • Cholesterol management and enhanced digestion [8].
  • Gut microbiota modulation: It positively influences gut health, supporting immunity and digestion [9].
  • Anti-inflammatory and anti-cancer properties: Berberine helps combat chronic inflammation and may reduce tumour progression [11].

In one clinical study, type 2 diabetes patients who took berberine for a month experienced significant reductions in fasting glucose, insulin resistance, blood lipids, and inflammation—comparable to the effects of metformin [12]. Additionally, a meta-analysis involving over 3,000 patients confirmed berberine’s effectiveness and safety in lowering fasting plasma glucose and HbA1c levels [7].

Berberine’s Unique GLP-1 Boost

Berberine also increases levels of GLP-1 (glucagon-like peptide-1), a hormone critical for metabolic health. GLP-1 helps regulate blood sugar by:

  • Stimulating insulin secretion when glucose levels rise.
  • Slowing gastric emptying to stabilize blood sugar.
  • Supporting appetite control and kidney function [14], [15].

Ceylon Cinnamon: The Perfect Companion

Ceylon cinnamon, known as “true cinnamon,” is another natural powerhouse for blood sugar regulation. Studies have shown that consuming just 3 grams daily can:

  • Reduce post-meal insulin levels.
  • Increase GLP-1 production, enhancing metabolic health [16].

The Atempo Naturals Difference

Our Berberine with Ceylon Cinnamon supplement is designed to deliver these incredible benefits in a clean, filler-free formula. Together, berberine and Ceylon cinnamon work synergistically to:

  • Support balanced blood sugar levels.
  • Enhance digestion and gut health.
  • Promote heart and brain health through anti-inflammatory effects.

Backed by Science

Every claim about our ingredients is rooted in rigorous scientific research. You can trust the science behind the benefits of berberine and cinnamon:

  1. Berberine’s glucose-lowering effects: Xie et al., 2022.
  2. Berberine’s impact on insulin resistance and lipids: Cao & Su, 2019.
  3. Cinnamon’s ability to boost GLP-1: Hlebowicz et al., 2009.

For a complete list of references, see the full bibliography below.

Take Control of Your Health Naturally

Incorporating Atempo Naturals Berberine with Ceylon Cinnamon into your daily routine could be the key to a healthier, more balanced life. With scientific backing and a commitment to quality, our supplement is your trusted ally for optimal metabolic health.

Explore the power of berberine and cinnamon today—naturally effective, scientifically proven.

Scientific References

[1]         K. Witek, K. Wydra, and M. Filip, “A High-Sugar Diet Consumption, Metabolism and Health Impacts with a Focus on the Development of Substance Use Disorder: A Narrative Review,” Nutrients, vol. 14, no. 14, p. 2940, Jul. 2022, doi: 10.3390/nu14142940. Available: https://pmc.ncbi.nlm.nih.gov/articles/PMC9323357/.

[2]         E. E. Blaak et al., “Impact of postprandial glycaemia on health and prevention of disease,” Obes. Rev., vol. 13, no. 10, p. 923, Oct. 2012, doi: 10.1111/j.1467-789X.2012.01011.x. Available: https://pmc.ncbi.nlm.nih.gov/articles/PMC3494382/.

[3]         R. Noordam et al., “High serum glucose levels are associated with a higher perceived age,” Age, vol. 35, no. 1, p. 189, Nov. 2011, doi: 10.1007/s11357-011-9339-9. Available: https://pmc.ncbi.nlm.nih.gov/articles/PMC3543736/.

[4]         D. Ye, T. J. Fairchild, L. Vo, and P. D. Drummond, “High Blood Glucose and Excess Body fat Enhance Pain Sensitivity and Weaken Pain Inhibition in Healthy Adults: A Single-blind Cross-over Randomized Controlled Trial,” J. Pain, vol. 24, no. 1, pp. 128–144, Jan. 2023, doi: 10.1016/j.jpain.2022.09.006. Available: https://www.jpain.org/article/S1526-5900(22)00404-7/fulltext.

[5]         K. K. Aldossari et al., “Association between Chronic Pain and Diabetes/Prediabetes: A Population-Based Cross-Sectional Survey in Saudi Arabia,” Pain Res. Manag., vol. 2020, p. 8239474, Jun. 2020, doi: 10.1155/2020/8239474. Available: https://pmc.ncbi.nlm.nih.gov/articles/PMC7333061/.

[6]         W. Li et al., “Effects of hyperglycemia on the progression of tumor diseases,” J. Exp. Clin. Cancer Res. CR, vol. 38, p. 327, Jul. 2019, doi: 10.1186/s13046-019-1309-6. Available: https://pmc.ncbi.nlm.nih.gov/articles/PMC6651927/.

[7]         W. Xie et al., “Glucose-lowering effect of berberine on type 2 diabetes: A systematic review and meta-analysis,” Front. Pharmacol., vol. 13, p. 1015045, Nov. 2022, doi: 10.3389/fphar.2022.1015045. Available: https://pmc.ncbi.nlm.nih.gov/articles/PMC9709280/.

[8]         C. Chen et al., “Berberine Improves Intestinal Motility and Visceral Pain in the Mouse Models Mimicking Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) Symptoms in an Opioid-Receptor Dependent Manner,” PLoS ONE, vol. 10, no. 12, p. e0145556, Dec. 2015, doi: 10.1371/journal.pone.0145556. Available: https://pmc.ncbi.nlm.nih.gov/articles/PMC4689480/.

[9]         F. Yang, R. Gao, X. Luo, R. Liu, and D. Xiong, “Berberine influences multiple diseases by modifying gut microbiota,” Front. Nutr., vol. 10, Aug. 2023, doi: 10.3389/fnut.2023.1187718. Available: https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2023.1187718/full.

[10]      M. Rondanelli et al., “Polycystic ovary syndrome management: a review of the possible amazing role of berberine,” Arch. Gynecol. Obstet., vol. 301, no. 1, p. 53, Feb. 2020, doi: 10.1007/s00404-020-05450-4. Available: https://pmc.ncbi.nlm.nih.gov/articles/PMC7028834/.

[11]      Y. Wang, Y. Liu, X. Du, H. Ma, and J. Yao, “The Anti-Cancer Mechanisms of Berberine: A Review,” Cancer Manag. Res., vol. 12, pp. 695–702, Jan. 2020, doi: 10.2147/CMAR.S242329. Available: https://www.tandfonline.com/doi/abs/10.2147/CMAR.S242329.

[12]      C. Cao and M. Su, “Effects of berberine on glucose-lipid metabolism, inflammatory factors and insulin resistance in patients with metabolic syndrome,” Exp. Ther. Med., vol. 17, no. 4, p. 3009, Feb. 2019, doi: 10.3892/etm.2019.7295. Available: https://pmc.ncbi.nlm.nih.gov/articles/PMC6434235/.

[13]      A. R. Utami, I. P. Maksum, and Y. Deawati, “Berberine and Its Study as an Antidiabetic Compound,” Biology, vol. 12, no. 7, p. 973, Jul. 2023, doi: 10.3390/biology12070973. Available: https://pmc.ncbi.nlm.nih.gov/articles/PMC10376565/.

[14]      W.-L. Yang et al., “Berberine Metabolites Stimulate GLP-1 Secretion by Alleviating Oxidative Stress and Mitochondrial Dysfunction,” Am. J. Chin. Med., vol. 52, no. 01, pp. 253–274, Jan. 2024, doi: 10.1142/S0192415X24500113. Available: https://www.worldscientific.com/doi/full/10.1142/S0192415X24500113.

[15]      T. D. Müller et al., “Glucagon-like peptide 1 (GLP-1),” Mol. Metab., vol. 30, p. 72, Sep. 2019, doi: 10.1016/j.molmet.2019.09.010. Available: https://pmc.ncbi.nlm.nih.gov/articles/PMC6812410/.

[16]      J. Hlebowicz et al., “Effects of 1 and 3 g cinnamon on gastric emptying, satiety, and postprandial blood glucose, insulin, glucose-dependent insulinotropic polypeptide, glucagon-like peptide 1, and ghrelin concentrations in healthy subjects2,” Am. J. Clin. Nutr., vol. 89, no. 3, pp. 815–821, Mar. 2009, doi: 10.3945/ajcn.2008.26807. Available: https://www.sciencedirect.com/science/article/pii/S0002916523237533.